Clinical trials
Infarction clinical trials
Below are recruiting infarction clinical trials, each written for real people, not researchers. We’re tracking 394 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07058857Recruiting
Ear stimulation test for heart attack recovery
This study tests whether gentle electrical stimulation on the tragus (small bump near your ear opening) can improve heart function in people having a first heart attack. This treatment is non-invasive and could help protect your heart from damage.
Semarang, Central of JavaAges 18–75 - NCT07072858Recruiting
Heart MRI to Predict Recovery After Heart Attack
This study is testing if a special heart MRI taken within a week of a STEMI heart attack can help doctors predict your recovery and future risks. It may help tailor your follow-up care.
BeijingAges 18–80 - NCT07077057Recruiting
AI tool for heart attack detection
This trial tests an artificial intelligence system that helps doctors quickly identify heart attacks (myocardial infarction) in patients with symptoms like chest pain or shortness of breath. It aims to speed up diagnosis and treatment.
Lugano, Canton TicinoAges 18 years+ - NCT07081568Recruiting
Vagus nerve stimulation for stroke recovery
This trial tests a device that uses gentle stimulation on your ear to help your brain recover movement and feeling after a stroke. It is for people who had their first ischemic stroke within the last two weeks.
Nanchang, JiangxiAges 18–80 - NCT07112820Recruiting
Heart imaging test for chest pain without ST elevation
This trial tests if a heart imaging scan (myocardial perfusion) can help doctors better diagnose heart attacks or other conditions in people who come to the hospital with chest pain but without ST elevation on their ECG. It aims to see if the scan adds valuable information before heart catheterization.
Paris, Ilede FranceAges 18 years+ - NCT07139860Recruiting
AI system for early warning after a heart attack
This study tests an artificial intelligence system that watches for early signs of complications after a heart attack. If you join, the system may help doctors catch problems sooner.
BeijingAges 18 years+ - NCT07143136RecruitingEarly Phase 1
Colchicine for heart attack patients with stents
This trial tests if giving colchicine early after a heart attack (when a drug-coated stent is placed) can help reduce complications. It looks at short-term benefits for people with Non-STEMI.
Asyut, Asyut GovernorateAges 18 years+ - NCT07181317Recruiting
Long-term study of young women after heart attack
This study continues to follow young women who had a heart attack to learn more about their long-term health. You can join if you already took part in the earlier WAMIF study.
ParisAges 18–60 - NCT07243769Recruiting
Comparing exercise types for heart rehab
This trial compares core, aerobic, and combined exercise in patients doing phase II cardiac rehab. It aims to find which type works best for heart recovery.
TaipeiAges 18 years+ - NCT07257198RecruitingPhase 3
Aspirin-free care with ticagrelor after a heart attack treated without stents or bypass
This trial tests whether taking ticagrelor (a blood thinner) alone, without aspirin, is safe and effective for people who have had a heart attack and are being treated with medication only (no stents or bypass surgery). It could mean fewer pills and possibly reduce bleeding risks.
Montreal, QuebecAges 18 years+ - NCT07276282RecruitingPhase 3
Ziltivekimab for heart attack patients with artery plaque
This trial tests a new drug called Ziltivekimab to see if it can reduce plaque buildup in the heart arteries after a heart attack. It may help prevent future heart problems by targeting inflammation.
BernAges 18 years+ - NCT07293832Recruiting
Beta-blocker therapy for heart attack patients
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
Thessaloniki, ThessalonikiAges 18–80 - NCT07295223RecruitingPhase 3
GLP-1 and SGLT2 drugs for heart attack recovery
This trial tests if combining GLP-1 and SGLT2 medications can reduce inflammation and improve heart function after a heart attack in people with type 2 diabetes and obesity. It looks for patients with a specific type of heart attack, elevated CRP levels, and preserved heart pumping ability.
León, GuanajuatoAges 18 years+ - NCT07354568Recruiting
Mixed heart and blood vessel shock study
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
Amiens, SommeAges 18 years+ - NCT07366684Recruiting
Heart attack study for adults 75 and older
This study looks at how frailty and other health factors affect recovery in people 75 and older who have had a heart attack or unstable chest pain. It may help doctors better understand who is at higher risk and how to improve care for older adults.
NišAges 75 years+ - NCT07388342Recruiting
CT heart scan after cardiac arrest without heart attack
This trial tests whether a special CT scan of the heart can help doctors see blockages in people who survived a cardiac arrest but did not have a typical heart attack. If you qualify, the CT scan might provide important information without needing a standard heart catheterization first.
Brussels, Vlaams BrabantAges 18 years+ - NCT00794001Recruiting
Timing feedback to improve treatment for heart attack patients
This trial studies whether feedback about treatment timing can help people who are having a specific type of heart attack get treated faster and more effectively. You may be eligible if you arrived for emergency heart catheter treatment soon after symptoms began.
Hildesheim, Lower SaxonyAges Any age - NCT01372800Recruiting
Study blood adiponectin levels and stroke/heart risk
This study measures a blood marker called adiponectin and looks at how it relates to heart and stroke (cardiovascular and cerebrovascular) problems over time. It may help doctors understand who is at higher risk, especially in Chinese participants.
Xi'an, ShaanxiAges 18–85 - NCT07427199Recruiting
Digital nutrition therapy after heart attack
This study tests whether a digital nutrition program (app- or online-based) can improve heart function after a heart attack. It compares the program to standard care for people who have had a STEMI heart attack.
Samsun, AtakumAges 19–65 - NCT07444957Recruiting
Safety of a drug-coated balloon for heart artery blockages
This study tests a special balloon coated with a drug called sirolimus to open blocked heart arteries. It may be an option for people with coronary artery disease who need a less invasive treatment.
Vigo, PontevedraAges 18 years+ - NCT07467213RecruitingPhase 3
Acid reflux drug for heart attack recovery
This trial tests if a newer acid-reducing drug is better than standard care for preventing stomach problems in people who recently had a heart attack and a stent placed. It could help those who need stomach protection while on blood thinners.
SeoulAges 19 years+ - NCT07469943Recruiting
Diabetes drug after heart attack
This study tests whether a diabetes medication can improve artery health and heart function after a heart attack. It is for people who have had a STEMI and also have diabetes or a weakened heart pump.
Athens, Rimini1/HaidariAges 18–80 - NCT07478003RecruitingPhase 3
Early steroid for severe heart attacks before reaching the hospital
This study tests whether giving a high dose of a steroid medication (glucocorticoid) early, before reaching the hospital, can help people having a severe type of heart attack called STEMI. If you are having this specific heart attack and meet the criteria, receiving this medication might improve your recovery.
AalborgAges 18 years+ - NCT07492537Recruiting
Helping with low mood after your first heart attack
This trial is for people who have just had their first heart attack and may be feeling some low mood or sadness. It aims to understand and help with these feelings early on, before they become a bigger problem.
Roma, ItaliaAges 18 years+
Hear when a new Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infarction?
- Yes. Clin2 currently lists 394 recruiting infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.